Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairment (MAFRI)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Pere Gines, Hospital Clinic of Barcelona
ClinicalTrials.gov Identifier:
NCT01133795
First received: May 19, 2010
Last updated: August 17, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2016
  Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)